A Phase II Trial Comparing the Quality of Life, Tolerability and Toxicity of PEG Intron With INTRON® A in Patients With Multiple Myeloma
Clinical trial NCT00323505 · COMPLETED
Trial details
- NCT number
- NCT00323505
- Sponsor
- Royal Marsden NHS Foundation Trust
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-03-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.